PKC β pseudosubstrate TFA, a biomedical marvel, emerges as an impeccable remedy boasting transformative potential for a plethora of maladies affiliated with protein kinase C (PKC) β. Functioning as an extraordinary pseudosubstrate, this phenomenal innovation proficiently curtails the robust activity of PKC β. A veritable panacea, this cutting-edge product propels unrivaled advancements in therapeutic protocols by precisely combating PKC β-associated afflictions such as malignant neoplasms, inflammatory reactions, and cardiovascular anomalies.
CAT# | GR2225 |
M.F/Formula | C179H295F3N62O40S3 |
M.W/Mr. | 4108.84 |
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
The 70-kDa heat shock protein (HSP70) contains three domains: the ATPase N-domain, which hydrolyses ATP, the sub ...
Developed by the German company Hoechst Marion Roussel and derived from genetic modification of hirudin, lepirud ...
Jingzhaotoxin-III (β-TRTX-Cj1α) is a kind of sodium channel gating modifier which is from the tarantula Chilobra ...
Since the discovery of Substance P (SP) in the early 1930s, its pharmacological actions have been extensively studied. SP has ...
DAMME (DA) is a guanine, often referred to as FK 33-824 (FK), which is a long-acting enkephalin analog. Natur ...